This demonstrated that reducing the production of IDO-1dependent neurotoxic metabolites could suppress epilepsy, attenuate neuronal damage, and ultimately inhibit glial cell activation and pro-inflammatory cytokine production (135). Here, IDO1 is linked to epilepsy.